Combating Dengue: A New Vaccine Arrives in colombia

A new weapon in the fight against dengue fever has arrived in colombia.The Japanese pharmaceutical giant, Takeda, has introduced its dengue vaccine, now accessible through the private market since 2024. This advancement marks a important step forward in dengue prevention, particularly for adults, who often face severe consequences from the disease.

Beyond Childhood: Why Adults Need Dengue Protection

While dengue is often perceived as a childhood illness, the reality is far more complex. Dr. Andrés Arias, a prominent member of the Colombian Association of Infectology, emphasized the critical need for adult vaccination in a recent interview. He highlighted that a significant portion of dengue-related fatalities occur in adults, making them a high-risk group.

This vaccine is authorized from four to 60 years. It is indeed crucial that the population understands that it is not exclusive for children.

The misconception that dengue immunity is lifelong is also dangerous. Individuals can be infected multiple times due to the existence of four distinct dengue virus serotypes,each with its own genetic variations capable of causing new infections. This underscores the importance of vaccination, even for those who have previously contracted dengue.

Understanding the Severity: Dengue’s Impact on Adults

Statistics reveal a concerning trend: approximately 30% of dengue-related deaths occur in adults, including older individuals. This highlights the vulnerability of the adult population and the potential severity of dengue infections in this age group. for those with a history of severe dengue episodes requiring hospitalization, whether in intensive care, general wards, or intermediate care units, vaccination should be a serious consideration, following medical advice.

Accessibility and Affordability: Making the Vaccine Available

recognizing the importance of widespread access, efforts are underway to make the Takeda dengue vaccine more affordable. Dr. Arias pointed out that financing options such as scheduled savings plans and compensation funds can help families manage the cost of vaccination, ensuring that more people can benefit from this crucial preventive measure.

Post-Infection Vaccination: A Key Strategy

Even if you’ve already had dengue, vaccination remains a vital step. Experts recommend waiting approximately three months after recovering from the illness, regardless of its severity, before initiating the immunization schedule. This post-infection vaccination strategy can substantially reduce the risk of future reinfections and their potential complications.

If I already gave you dengue,you must vaccinate. You must wait three months from the disease, whether mild or elaborate, and then start the immunization scheme. This can make a difference to future reinfection.

Global Dengue Threat: A Growing Concern

Dengue fever is a mosquito-borne viral disease that poses a significant threat to global public health. According to the World Health Association (WHO), the incidence of dengue has increased dramatically in recent decades, with an estimated 100-400 million infections occurring each year. The introduction of effective vaccines like Takeda’s represents a crucial step in controlling the spread of this debilitating disease.